Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation:: a requirement for Bcl-XL and XIAP in the prolonged survival of monocytic cells

被引:31
作者
Miranda, MB
Dyer, KF
Grandis, JR
Johnson, DE
机构
[1] Univ Pittsburgh, Div Hematol Oncol, Hillman Canc Ctr, Dept Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA
关键词
apoptosis; Bcl-X-L; XIAP; STAT3; caspase-3; MEK/ERK;
D O I
10.1038/sj.leu.2402779
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neutrophils and monocytes/macrophages are derived from common progenitors, but exhibit markedly different lifespans. Differentiated neutrophils are short-lived and die rapidly by apoptosis, while monocytic cells are longer-lived. In this report we used the HL-60 cell line as a model system to identify differences in apoptotic pathways which might account for the differing lifespans of granulocytic vs monocytic cells. We observed that induction of granulocytic differentiation by retinoic acid led to robust activation of the executioner protease caspase-3, and early onset of apoptosis. By contrast, caspase-3 was not appreciably activated during phorbol 12-myristate 13-acetate (PMA)-induced monocytic differentiation, and apoptosis was delayed in these cells. Since the activation of caspase-3 is inhibited by members of the inhibitor of apoptosis (IAP) and Bcl-2 protein families, we investigated the expression of anti-apoptotic members of these families. Induction of monocytic differentiation led to marked upregulation of the IAP protein XIAP, as well as the Bcl-2 family member Bcl-X-L. During granulocytic differentiation the levels of XIAP progressively declined, while Bcl-X-L levels remained unchanged. A different IAP protein, survivin, was downregulated during differentiation along either lineage, as was expression of Bcl-2. The upregulation of Bcl-X-L during monocytic differentiation coincided with phosphorylation/activation of STAT3, a known activator of bcl-X gene transcription. Moreover, Bcl-X-L upregulation was dependent on MEK/ERK signaling. Upregulation of XIAP proceeded in a MEK/ERK-independent fashion. Treatment with antisense Bcl-X-L or XIAP oligonucleotides resulted in significant loss of viability in cells differentiating along the monocytic lineage. Together, these findings indicate that the levels of XIAP and Bcl-X-L are regulated by distinct pathways during monocytic differentiation and that upregulation of these proteins contributes to the increased longevity of cells in the monocytic lineage.
引用
收藏
页码:390 / 400
页数:11
相关论文
共 58 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[3]   LEUKOKINETIC STUDIES .14. BLOOD NEUTROPHIL KINETICS IN CHRONIC, STEADY-STATE NEUTROPENIA [J].
BISHOP, CR ;
ROTHSTEIN, G ;
ASHENBRUCKER, HE ;
ATHENS, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (08) :1678-+
[4]   Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs [J].
Blalock, WL ;
Weinstein-Oppenheimer, C ;
Chang, F ;
Hoyle, PE ;
Wang, XY ;
Algate, PA ;
Franklin, RA ;
Oberhaus, SM ;
Steelman, LS ;
McCubrey, JA .
LEUKEMIA, 1999, 13 (08) :1109-1166
[5]   INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID [J].
BREITMAN, TR ;
SELONICK, SE ;
COLLINS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2936-2940
[6]   Cytokine-regulated expression of survivin in myeloid leukemia [J].
Carter, BZ ;
Milella, M ;
Altieri, DC ;
Andreeff, M .
BLOOD, 2001, 97 (09) :2784-2790
[7]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[8]   Stat3 and G-CSF-induced myeloid differentiation [J].
Chakraborty, A ;
Tweardy, DJ .
LEUKEMIA & LYMPHOMA, 1998, 30 (5-6) :433-+
[9]  
COHEN GM, 1997, BIOCHEM J, V260, P17
[10]   INDUCTION OF MORPHOLOGICAL AND FUNCTIONAL-DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA-CELLS (HL-60) BY COMPOUNDS WHICH INDUCE DIFFERENTIATION OF MURINE LEUKEMIA-CELLS [J].
COLLINS, SJ ;
BODNER, A ;
TING, R ;
GALLO, RC .
INTERNATIONAL JOURNAL OF CANCER, 1980, 25 (02) :213-218